Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
102.95
-4.79 (-4.44%)
Mar 9, 2026, 2:08 PM EDT - Market open
Glaukos Market Cap
Glaukos has a market cap or net worth of $5.98 billion as of March 9, 2026. Its market cap has decreased by -31.12% in one year.
Market Cap
5.98B
Enterprise Value
5.80B
1-Year Change
-31.12%
Ranking
Category
Stock Price
$102.95
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $5.98B, an increase of 497.84%. That is a compound annual growth rate of 18.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.26B | -3.52% |
| Dec 31, 2025 | 6.49B | -21.56% |
| Dec 31, 2024 | 8.27B | 113.12% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | - |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penumbra | 13.29B |
| Globus Medical | 11.78B |
| Masimo | 9.16B |
| Bio-Rad Laboratories | 7.34B |
| Bio-Rad Laboratories | 7.28B |
| Bruker | 5.58B |
| TransMedics Group | 4.45B |
| iRhythm Holdings | 3.99B |